En busca de la seguridad jurídica perdida
EL GLOBAL
En España estamos obsesionados con la unidad de mercado, y el debate territorial está siempre tan presente que, al hablar de ello, enseguida aparece en escena el principio de equidad (que tiene paralelismos con el llamado “café para todos”), y de ahí poco falta para llegar a otras discusiones con un mayor calado. Tanta política,... Read More
El fin nunca justifica los medios
EL GLOBAL
Es evidente que algo no acaba de funcionar del todo bien en nuestro país cuando la Junta de Andalucía se permite el lujo de descalificar públicamente el recurso de la industria farmacéutica frente a la nueva subasta de medicamentos, la cuarta ya, asegurando que este supone un “ataque” contra la sanidad pública andaluza. ¿Pero es... Read More
New regulation of the reference price system and of homogeneous groups in the National Health System
Royal Decree 177/2014, of 21 March 2014 also deals with information systems regarding the reimbursement and prices of medicinal products and medical devices
CAPSULAS Nº 151
Introduction After long months of negotiation this very important piece of regulation has finally been approved. The State Council, when reporting on the draft, already pointed out that this is undoubtedly a complex issue, and that therefore it would be convenient that the Preamble offered a simple and comprehensible explanation. In this CAPSULAS Newsletter we... Read More
‘Dallas Buyers Club’ y la industria
EL GLOBAL
El fin de semana pasado vi Dallas Buyers Club, una película dura e imprescindible para quienes tengan interés en la industria farmacéutica. Antes leí en EG las declaraciones de Silvia Gartner, del Hospital Vall d’Hebron explicando los avances en el tratamiento de la fibrosis quística y lamentándose de que un fármaco eficaz contra esta no... Read More
Jordi Faus makes a presentation about the Royal Decree on the Reference Price System in the first Online Seminar organized by CEFI
Royal Decree 177/2014 of 21 March 2014 also regulates the information systems regarding financing and prices of medicinal products and medical devices
After long months of negotiation, this very important regulation on reference prices, the system of homogeneous groups, and certain information systems regarding pricing and reimbursement of medicinal products has been approved. The State Council, when reporting on the draft, already pointed out that this is a complex issue, difficult to understand for those who do... Read More
Royal Decree 177/2014 on the Reference Price System
Presentation at the CEFI online Seminar on Reference Prices
After long months of negotiation, this very important regulation on reference prices, the system of homogeneous groups, and certain information systems regarding pricing and reimbursement of medicinal products has been approved. The State Council, when reporting on the draft, already pointed out that this is a complex issue, difficult to understand for those who do... Read More
La innovación vuelve a estar contra las cuerdas
EL GLOBAL
En las facultades de derecho se enseña que la motivación de los actos administrativos es algo muy importante, tanto que la falta de la misma puede llegar a comportar su anulación. En las disposiciones como el recientemente publicado Real Decreto 177/2014 de precios de referencia, agrupaciones homogéneas y sistemas de información en materia de financiación... Read More
Ahora nos toca pagar a todos
EL GLOBAL
La publicación de la sentencia del Tribunal Supremo, confirmando la anulación de la Orden de Precios de Referencia de diciembre de 2009, ha levanta un revuelo lógico dadas sus posibles implicaciones económicas. El alto tribunal, como era de esperar, acoge el cambio de criterio jurisprudencial iniciado por la Audiencia Nacional en el 2010, confirmando que,... Read More
Introducción a la regulación del sector farmacéutico
Presentation at the Course on Regulated Areas in the Master in Professional Law Practice of Pompeu Fabra University
Jordi Faus lectures on pharmaceutical law at the master for graduate law students. The Universitat Pompeu Fabra in Barcelona has selected Faus & Moliner to participate in the course on regulated sectors that is part of the Master program for graduate law students. Faus & Moliner partner Jordi Faus has lectured on the rules that... Read More
Faus & Moliner collaborates with the Universitat Pompeu Fabra in Barcelona
Jordi Faus lectures on pharmaceutical law at the master for graduate law students
The Universitat Pompeu Fabra in Barcelona has selected Faus & Moliner to participate in the course on regulated sectors that is part of the Master program for graduate law students. Faus & Moliner partner Jordi Faus has lectured on the rules that apply to medicinal products in Spain and in the European Union. In his... Read More